A Population-Based Pharmacokinetic Model Approach to Pantoprazole Dosing for Obese Children and Adolescents

被引:0
作者
Valentina Shakhnovich
P. Brian Smith
Jeffrey T. Guptill
Laura P. James
David N. Collier
Huali Wu
Chad E. Livingston
Jian Zhao
Gregory L. Kearns
Michael Cohen-Wolkowiez
机构
[1] The Children’s Mercy Hospital,
[2] Duke Clinical Research Institute,undefined
[3] Arkansas Children’s Hospital,undefined
[4] East Carolina University,undefined
[5] The Emmes Corporation,undefined
[6] University of Missouri-Kansas City School of Medicine,undefined
来源
Pediatric Drugs | 2018年 / 20卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:483 / 495
页数:12
相关论文
共 175 条
[1]  
Chai G(2012)Trends of outpatient prescription drug utilization in US Children 2002–2010 23-31
[2]  
Governale L(2014)Prevalence of childhood and adult obesity in the United States, 2011–2012 JAMA 311 806-814
[3]  
McMahon AW(2011)Extreme childhood obesity is associated with increased risk for gastroesophageal reflux disease in a large population-based study Int J Pediatr Obes. 6 e267-e268
[4]  
Trinidad JP(2003)The use of proton pump inhibitors in children: a comprehensive review Paediatr Drugs 5 25-40
[5]  
Staffa J(2000)Effects of obesity on pharmacokinetics: implications for drug therapy Clin Pharmacokinet 39 215-231
[6]  
Murphy D(2012)Impact of obesity on drug meatabolism and elimination in adults and children Clin Pharmacokinet 51 277-304
[7]  
Ogden CL(2015)Drug dosing and pharmacokinetics in children with obesity: a systematic review JAMA Pediatr. 169 678-685
[8]  
Carroll MD(2015)Drug disposition in obesity: toward evidence-based dosing Annu Rev Pharmacol Toxicol 55 149-167
[9]  
Kit BK(2018)Obese children require lower doses of pantoprazole than nonobese peers to achieve equal systemic drug exposures J Pediatr 193 e1-1932
[10]  
Flegal KM(2015)Gaps in drug dosing for obese children: a systematic review of commonly prescribed emergency care medications Clin Ther 37 1924-1923